This in vitro finding was consistent with the demonstration of a significant decrease in the in vivo expression of iNOS mRNA in the lungs of FP-treated mice 90 minutes after bacterial infection (Figure 5B). The gene discussed is NOS2; the disease is bacterial infectious disease.